Matinas BioPharma Holdings, Inc.
MTNB
$0.62
$0.0294.91%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -47.05% | -40.74% | -36.42% | -67.37% | -52.17% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -60.22% | -48.00% | -35.84% | -35.47% | -69.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Current Assets | -48.37% | -41.26% | -36.31% | -63.52% | -54.99% |
|
|
|||||
| Total Current Assets | -48.37% | -41.26% | -36.31% | -63.52% | -54.99% |
| Net Property, Plant & Equipment | -56.95% | -18.40% | -17.27% | -13.36% | -12.66% |
| Long-term Investments | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -23.53% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -49.65% | -30.93% | -28.39% | -48.75% | -43.99% |
|
|
|||||
| Total Accounts Payable | -81.52% | -58.20% | -60.60% | -8.33% | -16.83% |
| Total Accrued Expenses | 24.74% | -40.98% | 5.10% | 6.07% | -36.81% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.89% | 15.86% | 16.15% | 16.47% | 16.17% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.68% | -34.22% | -7.61% | 5.38% | -38.82% |
|
|
|||||
| Total Current Liabilities | 1.68% | -34.22% | -7.61% | 5.38% | -38.82% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -26.49% | -24.03% | -21.97% | -20.21% | -18.57% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -24.63% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | -13.78% | -27.75% | -14.73% | -10.38% | -28.40% |
|
|
|||||
| Common Stock & APIC | 6.34% | 6.92% | 7.11% | 2.47% | 2.60% |
| Retained Earnings | -13.81% | -12.41% | -13.95% | -14.70% | -15.03% |
| Treasury Stock & Other | -- | -- | 90.08% | 77.48% | 73.18% |
| Total Common Equity | -60.56% | -31.84% | -31.42% | -55.38% | -47.47% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -60.56% | -31.84% | -31.42% | -55.38% | -47.47% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -60.56% | -31.84% | -31.42% | -55.38% | -47.47% |
|
|
|||||